CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins-Reference-Cited by-同舟云学术

CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins

Published:2018-02-23 Issue:5 Volume:93 Page:489-503
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Zhong Guo,Ortiz David,Zelter Alex,Nath Abhinav,Isoherranen Nina

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference57 articles.

1. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.

2. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid;Allenby;J Biol Chem,1994

3. A sensitive and specific method for measurement of multiple retinoids in human serum with UHPLC-MS/MS

4. Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription

5. Classical force field parameters for the heme prosthetic group of cytochromec

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of CYP26A1 inhibition assay for high‐throughput screening;Biotechnology Journal;2024-06

2. Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism;Molecular Pharmacology;2024-04-05

3. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid;PLOS ONE;2024-04-01

4. Unraveling the underlying mechanism of interactions between astaxanthin geometrical isomers and bovine serum albumin;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-03

5. Retinoid Treatment for Oral Leukoplakia: Current Evidence and Future Development;Journal of Clinical Pharmacy and Therapeutics;2024-02-20